MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials

The goal of this work was to assess statistical power to detect treatment effects in Alzheimer’s disease (AD) clinical trials using magnetic resonance imaging (MRI)–derived brain biomarkers. We used unbiased tensor-based morphometry (TBM) to analyze n = 5,738 scans, from Alzheimer’s Disease Neuroima...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurobiol Aging
Main Authors: Hua, Xue, Ching, Christopher R.K., Mezher, Adam, Gutman, Boris A., Hibar, Derrek P., Bhatt, Priya, Leow, Alex D., Jack, Clifford R., Bernstein, Matt A., Weiner, Michael W., Thompson, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4827255/
https://ncbi.nlm.nih.gov/pubmed/26545631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2015.09.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados